Navigating the Regulatory Landscape for Topical Generics: Outsourcing-Pharma


July 29, 2021

The development and manufacture of topical generic products pose various challenges for pharma companies and their CDMOs, particularly when it comes to adhering to global regulations.

In this article with Outsourcing-Pharma, Lynn Allen, Vice President of Business Development at MedPharm, discusses the evolution of the topical generics market and the key regulatory requirements pharma companies must comply with.

Read the full article here.

About MedPharm
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm specialises in reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through its unique, cost-effective, and industry-leading performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognised for their scientific rigour by regulators and investors. MedPharm has fully established Centers of Excellence in the USA and the UK.